MA29030B1 - 2-alcoxy-3,4,5-trihydroxy-alkylamides, leur preparation, compositions les contenant et utilisation - Google Patents
2-alcoxy-3,4,5-trihydroxy-alkylamides, leur preparation, compositions les contenant et utilisationInfo
- Publication number
- MA29030B1 MA29030B1 MA29917A MA29917A MA29030B1 MA 29030 B1 MA29030 B1 MA 29030B1 MA 29917 A MA29917 A MA 29917A MA 29917 A MA29917 A MA 29917A MA 29030 B1 MA29030 B1 MA 29030B1
- Authority
- MA
- Morocco
- Prior art keywords
- alcoxy
- alkylamides
- trihydroxy
- preparation
- compositions containing
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D223/00—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom
- C07D223/02—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom not condensed with other rings
- C07D223/06—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom not condensed with other rings with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D223/12—Nitrogen atoms not forming part of a nitro radical
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/18—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
- C07D207/22—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D205/00—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom
- C07D205/02—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings
- C07D205/06—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
- C07D205/08—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with one oxygen atom directly attached in position 2, e.g. beta-lactams
- C07D205/085—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with one oxygen atom directly attached in position 2, e.g. beta-lactams with a nitrogen atom directly attached in position 3
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/18—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
- C07D207/22—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D207/24—Oxygen or sulfur atoms
- C07D207/26—2-Pyrrolidones
- C07D207/273—2-Pyrrolidones with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to other ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/18—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
- C07D207/22—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D207/24—Oxygen or sulfur atoms
- C07D207/26—2-Pyrrolidones
- C07D207/273—2-Pyrrolidones with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to other ring carbon atoms
- C07D207/277—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/68—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
- C07D211/72—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D211/74—Oxygen atoms
- C07D211/76—Oxygen atoms attached in position 2 or 6
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/38—Nitrogen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D223/00—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom
- C07D223/14—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
- C07D223/16—Benzazepines; Hydrogenated benzazepines
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D243/00—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms
- C07D243/06—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms having the nitrogen atoms in positions 1 and 4
- C07D243/08—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms having the nitrogen atoms in positions 1 and 4 not condensed with other rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D281/00—Heterocyclic compounds containing rings of more than six members having one nitrogen atom and one sulfur atom as the only ring hetero atoms
- C07D281/02—Seven-membered rings
- C07D281/04—Seven-membered rings having the hetero atoms in positions 1 and 4
- C07D281/06—Seven-membered rings having the hetero atoms in positions 1 and 4 not condensed with other rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D281/00—Heterocyclic compounds containing rings of more than six members having one nitrogen atom and one sulfur atom as the only ring hetero atoms
- C07D281/02—Seven-membered rings
- C07D281/04—Seven-membered rings having the hetero atoms in positions 1 and 4
- C07D281/08—Seven-membered rings having the hetero atoms in positions 1 and 4 condensed with carbocyclic rings or ring systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pyrrole Compounds (AREA)
- Quinoline Compounds (AREA)
- Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)
- Hydrogenated Pyridines (AREA)
- Plural Heterocyclic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR0412645A FR2878528B1 (fr) | 2004-11-29 | 2004-11-29 | 2-alcoxy-3,4,5-trihydroxy-alkylamides, leur preparation, compositions les contenant et utilisation |
Publications (1)
Publication Number | Publication Date |
---|---|
MA29030B1 true MA29030B1 (fr) | 2007-11-01 |
Family
ID=34951749
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MA29917A MA29030B1 (fr) | 2004-11-29 | 2007-05-17 | 2-alcoxy-3,4,5-trihydroxy-alkylamides, leur preparation, compositions les contenant et utilisation |
Country Status (22)
Country | Link |
---|---|
US (1) | US7550453B2 (fr) |
EP (1) | EP1819679A2 (fr) |
JP (1) | JP2008521780A (fr) |
KR (1) | KR20070091120A (fr) |
CN (1) | CN101065362A (fr) |
AR (1) | AR052328A1 (fr) |
AU (1) | AU2005308710A1 (fr) |
BR (1) | BRPI0516666A (fr) |
CA (1) | CA2595305A1 (fr) |
CR (1) | CR9114A (fr) |
EA (1) | EA011392B1 (fr) |
FR (1) | FR2878528B1 (fr) |
IL (1) | IL183044A0 (fr) |
MA (1) | MA29030B1 (fr) |
MX (1) | MX2007006241A (fr) |
NO (1) | NO20073026L (fr) |
PE (1) | PE20061121A1 (fr) |
TN (1) | TNSN07137A1 (fr) |
TW (1) | TW200630343A (fr) |
UY (1) | UY29236A1 (fr) |
WO (1) | WO2006056696A2 (fr) |
ZA (1) | ZA200704342B (fr) |
Families Citing this family (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2878525B1 (fr) * | 2004-11-29 | 2007-02-23 | Aventis Pharma Sa | Bengamides possedant un cycle caprolactame substitue, procede de preparation, compositions les contenant et utilisation |
FR2901554B1 (fr) * | 2006-05-24 | 2011-04-01 | Sanofi Aventis | 2-alcoxy-3,4,5-trihydroxy-alkylamide-benzazepine, leur preparation, compositions les contenant et utilisation |
FR2901555A1 (fr) | 2006-05-24 | 2007-11-30 | Sanofi Aventis Sa | 2-alcoxy-3,4,5-trihydroxy-alkylamide-benzothiazepine, leur preparation, compositions les contenant et utilisation |
FR2901556A1 (fr) | 2006-05-24 | 2007-11-30 | Sanofi Aventis Sa | Derives de 2-alcoxy-3,4,5-trihydroxy-alkylamide, leur preparation, compositions les contenant et utilisation |
CN101092384A (zh) * | 2006-06-22 | 2007-12-26 | 中国科学院上海药物研究所 | 一类α-氨基-N-取代酰胺化合物、其组合物及用途 |
CN101456824B (zh) * | 2007-12-11 | 2013-04-17 | 中国科学院上海药物研究所 | α-氨基-N-取代酰胺化合物、包含该化合物的药物组合物及其用途 |
US8153808B2 (en) | 2008-12-23 | 2012-04-10 | Roche Palo Alto Llc | Dihydropyridone amides as P2X7 modulators |
SG172785A1 (en) | 2008-12-23 | 2011-08-29 | Hoffmann La Roche | Dihydropyridone amides as p2x7 modulators |
SG172336A1 (en) | 2008-12-23 | 2011-07-28 | Hoffmann La Roche | Dihydropyridone amides as p2x7 modulators |
SG172382A1 (en) | 2008-12-23 | 2011-07-28 | Hoffmann La Roche | Dihydropyridone ureas as p2x7 modulators |
JP5405592B2 (ja) | 2008-12-23 | 2014-02-05 | エフ.ホフマン−ラ ロシュ アーゲー | P2x7モジュレーターとしてのジヒドロピリドンアミド |
WO2020113094A1 (fr) | 2018-11-30 | 2020-06-04 | Nuvation Bio Inc. | Composés pyrrole et pyrazole et leurs procédés d'utilisation |
Family Cites Families (18)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4692522A (en) | 1985-04-01 | 1987-09-08 | Merck & Co., Inc. | Benzofused lactams useful as cholecystokinin antagonists |
US4831135A (en) | 1986-06-18 | 1989-05-16 | The Regents Of The University Of California | Bengamide anthelmintics |
US5283241A (en) | 1992-08-28 | 1994-02-01 | Merck & Co., Inc. | Benzo-fused lactams promote release of growth hormone |
GB9411841D0 (en) | 1994-06-14 | 1994-08-03 | Pharma Mar Sa | New antitumoral compounds from jaspis sponge |
JP2002241368A (ja) | 1997-02-18 | 2002-08-28 | Shionogi & Co Ltd | 新規ベンゾラクタム誘導体およびそれを含有する医薬組成物 |
US6239127B1 (en) | 1999-11-17 | 2001-05-29 | Novartis Ag | Certain substituted caprolactams, pharmaceutical compositions containing them and a process for their preparation |
CO5140099A1 (es) * | 1998-11-17 | 2002-03-22 | Novartis Ag | Ciertas caprolactamas sustituidas, composiciones farmaceuticas que las contienen, y su uso en el tratamiento de tumores |
ATE383341T1 (de) * | 2000-05-11 | 2008-01-15 | Novartis Pharma Gmbh | Substituierte caprolactam carbonate und ether sowie deren verwendung als anti-tumor wirkstoffe |
AU2002217020A1 (en) * | 2000-11-14 | 2002-05-27 | Novartis Ag | Method for screening anti-proliferative compounds and inhibiting tumor growth |
US6545148B2 (en) | 2001-03-12 | 2003-04-08 | Novartis Ag | Process for preparing certain substituted caprolactams |
JP2004262793A (ja) | 2003-02-28 | 2004-09-24 | Noyaku Bio Technology Kaihatsu Gijutsu Kenkyu Kumiai | 化合物n−9011、その製造法及び用途 |
JP2006528611A (ja) * | 2003-07-25 | 2006-12-21 | ノバルティス アクチエンゲゼルシャフト | 置換ラクタムおよびそれらの抗がん剤としての使用 |
US7153846B2 (en) | 2003-10-24 | 2006-12-26 | Sanofi-Aventis Deutschland Gmbh | Bengamide derivatives, process for preparing them, and their use |
DE10349669B3 (de) | 2003-10-24 | 2005-05-25 | Aventis Pharma Deutschland Gmbh | Bengamide-Derivate, Verfahren zu ihrer Herstellung und ihre Verwendung |
FR2878525B1 (fr) * | 2004-11-29 | 2007-02-23 | Aventis Pharma Sa | Bengamides possedant un cycle caprolactame substitue, procede de preparation, compositions les contenant et utilisation |
FR2901555A1 (fr) | 2006-05-24 | 2007-11-30 | Sanofi Aventis Sa | 2-alcoxy-3,4,5-trihydroxy-alkylamide-benzothiazepine, leur preparation, compositions les contenant et utilisation |
FR2901556A1 (fr) | 2006-05-24 | 2007-11-30 | Sanofi Aventis Sa | Derives de 2-alcoxy-3,4,5-trihydroxy-alkylamide, leur preparation, compositions les contenant et utilisation |
FR2901554B1 (fr) | 2006-05-24 | 2011-04-01 | Sanofi Aventis | 2-alcoxy-3,4,5-trihydroxy-alkylamide-benzazepine, leur preparation, compositions les contenant et utilisation |
-
2004
- 2004-11-29 FR FR0412645A patent/FR2878528B1/fr not_active Expired - Fee Related
-
2005
- 2005-11-22 PE PE2005001366A patent/PE20061121A1/es not_active Application Discontinuation
- 2005-11-25 JP JP2007542046A patent/JP2008521780A/ja active Pending
- 2005-11-25 ZA ZA200704342A patent/ZA200704342B/en unknown
- 2005-11-25 AR ARP050104935A patent/AR052328A1/es unknown
- 2005-11-25 CA CA002595305A patent/CA2595305A1/fr not_active Abandoned
- 2005-11-25 EP EP05822934A patent/EP1819679A2/fr not_active Withdrawn
- 2005-11-25 MX MX2007006241A patent/MX2007006241A/es active IP Right Grant
- 2005-11-25 EA EA200701172A patent/EA011392B1/ru not_active IP Right Cessation
- 2005-11-25 BR BRPI0516666-7A patent/BRPI0516666A/pt not_active IP Right Cessation
- 2005-11-25 WO PCT/FR2005/002932 patent/WO2006056696A2/fr active Application Filing
- 2005-11-25 CN CNA2005800407464A patent/CN101065362A/zh active Pending
- 2005-11-25 KR KR1020077012024A patent/KR20070091120A/ko not_active Application Discontinuation
- 2005-11-25 AU AU2005308710A patent/AU2005308710A1/en not_active Withdrawn
- 2005-11-28 TW TW094141645A patent/TW200630343A/zh unknown
- 2005-11-29 UY UY29236A patent/UY29236A1/es unknown
-
2007
- 2007-04-13 TN TNP2007000137A patent/TNSN07137A1/fr unknown
- 2007-05-07 IL IL183044A patent/IL183044A0/en unknown
- 2007-05-09 CR CR9114A patent/CR9114A/es not_active Application Discontinuation
- 2007-05-17 MA MA29917A patent/MA29030B1/fr unknown
- 2007-05-24 US US11/753,160 patent/US7550453B2/en not_active Expired - Fee Related
- 2007-06-13 NO NO20073026A patent/NO20073026L/no not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
CR9114A (es) | 2008-01-21 |
WO2006056696A3 (fr) | 2006-08-31 |
CA2595305A1 (fr) | 2006-06-01 |
EA200701172A1 (ru) | 2007-10-26 |
EA011392B1 (ru) | 2009-02-27 |
JP2008521780A (ja) | 2008-06-26 |
FR2878528A1 (fr) | 2006-06-02 |
PE20061121A1 (es) | 2006-11-10 |
AR052328A1 (es) | 2007-03-14 |
MX2007006241A (es) | 2007-07-25 |
IL183044A0 (en) | 2007-09-20 |
UY29236A1 (es) | 2006-06-30 |
EP1819679A2 (fr) | 2007-08-22 |
FR2878528B1 (fr) | 2008-05-16 |
BRPI0516666A (pt) | 2008-09-16 |
KR20070091120A (ko) | 2007-09-07 |
TNSN07137A1 (en) | 2008-11-21 |
TW200630343A (en) | 2006-09-01 |
US20070244087A1 (en) | 2007-10-18 |
NO20073026L (no) | 2007-08-27 |
CN101065362A (zh) | 2007-10-31 |
US7550453B2 (en) | 2009-06-23 |
WO2006056696A2 (fr) | 2006-06-01 |
AU2005308710A1 (en) | 2006-06-01 |
ZA200704342B (en) | 2008-07-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MA29030B1 (fr) | 2-alcoxy-3,4,5-trihydroxy-alkylamides, leur preparation, compositions les contenant et utilisation | |
FR15C0037I2 (fr) | Compositions monodisperses contenant du naloxol pegyle | |
FR2885904B1 (fr) | Nouveaux derives du fluorene, compositions les contenant et utilisation | |
IL173299A (en) | 2,4-Pyrimidindiamine derivatives, preparations containing them and their use | |
FR2843023B1 (fr) | Compositions cosmetiques ou dermopharmaceutiques contenant du kombucha. | |
FR2880802B1 (fr) | Composition cosmetique ou dermopharmaceutique contenant un extrait d'euglene | |
IL229778A0 (en) | Antibodies against ir-igf, their use and preparations that include them | |
DE60325255D1 (de) | Duftzusammensetzung | |
BRPI0508259A (pt) | derivado heterocìclico fundido, composição medicinal contendo o mesmo, e uso medicinal do mesmo | |
DE60138711D1 (de) | Antikörper gegen il-12, zusammensetzungen, verfahren und verwendungen | |
FR2789388B1 (fr) | Composes stabilisants, composition les contenant et leur utilisation | |
ZA200606792B (en) | Fused heterocycle derivative, medicinal composition containing the same, and medicinal use thereof | |
DE602005027899D1 (de) | Mundpflegezusammensetzung mit dem extrakt von unoxidierter kamelie | |
MA28527B1 (fr) | Formulations orales contenant licarbazepine | |
IS7501A (is) | thurrdufts innöndunar samsetning | |
FR2903406B1 (fr) | Derives de pyrazolylbenzimidazole,compositions les contenant et utilisation | |
DE602006001330D1 (de) | Herstellung von 1-(Alkoxysilyl)ethyl-1,1,3,3-tetramethyldisiloxan | |
IL181216A0 (en) | 3, 5-seco-4-norcholestane derivatives and pharmaceutical compositions containing the same | |
FR2873377B1 (fr) | Derives d'azasucre, inhibiteurs d'heparanases, leur procede de preparation, les compositions en contenant et leur utilisation | |
FR2855825B1 (fr) | Produits aryl-heteroaromatiques, compositions les contenant et utilisation | |
FR2901554B1 (fr) | 2-alcoxy-3,4,5-trihydroxy-alkylamide-benzazepine, leur preparation, compositions les contenant et utilisation | |
EP1797074A4 (fr) | Composes, compositions les contenant, leur preparation et leur utilisation | |
FR2817257B1 (fr) | Cyclohexyl(alkyl)-propanolamines, leur preparation et compositions pharmaceutiques en contenant | |
FR2796382B1 (fr) | Organopolysiloxanes modifies, leur preparation, et compositions en contenant | |
FR2861290B1 (fr) | Composition cosmetique thermogonflante. |